Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

Dermatologists reveal the silent signs of skin cancer that are often overlooked, such as a pimple that doesn't go away. The ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...

Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach ...

An investigational immunomodulator gel significantly improved malodor and measures related to pain and quality of life for ...

Share on Pinterest Scientists have taken a new approach to treat brain cancer with the help of two supplements. Elena Popova/Getty Images A combination of two supplements — resveratrol and copper — ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca (AZN.L), opens new tab and partner Daiichi Sankyo's (4568.T), opens new tab Enhertu in combination with Roche's (ROG.S ...

VT-1953 treatment over 14 days resulted in highly statistically significant improvements in bad smell or malodor associated with malignant fungating wound (primary endpoint) (P = 0.002).

Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method from CU Boulder researchers uses sound waves to soften tumors and could be a ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors. Cell therapies, which have primarily made waves in the treatment of patients with blood ...